Federal contract award

80NM0021F0065

CROSS DISCIPLINARY DATA DRIVEN SCIENCE TECHNOLOGIES FOR CANCER RESEARCH (82-109597)

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyNational Aeronautics and Space Administration
OfficeNASA MANAGEMENT OFFICE -- JPL
NAICS541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSCAR12 — SPACE R&D SERVICES; SPACE FLIGHT, RESEARCH AND SUPPORTING ACTIVITIES; APPLIED RESEARCH
Parent award / vehicle80NM0018D0004
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$7.2M
Current contract value$7.8M
Potential contract value / ceiling$7.8M
Start dateSep 15, 2021
Current end dateSep 30, 2026
Potential end dateSep 30, 2026
Latest award activityAug 13, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 13, 2026P00007$0CROSS DISCIPLINARY DATA DRIVEN SCIENCE TECHNOLOGIES FOR CANCER RESEARCH (82-109597)
Sep 24, 2025P00006$1.1MCROSS DISCIPLINARY DATA DRIVEN SCIENCE TECHNOLOGIES FOR CANCER RESEARCH (82-109597)
Sep 23, 2024P00005$1.5MCROSS DISCIPLINARY DATA DRIVEN SCIENCE TECHNOLOGIES FOR CANCER RESEARCH (82-109597)
Sep 5, 2024P00004$0CROSS DISCIPLINARY DATA DRIVEN SCIENCE TECHNOLOGIES FOR CANCER RESEARCH (82-109597)
Aug 31, 2023P00003$0CROSS DISCIPLINARY DATA DRIVEN SCIENCE TECHNOLOGIES FOR CANCER RESEARCH (82-109597)
Aug 29, 2023P00002$1.6MCROSS DISCIPLINARY DATA DRIVEN SCIENCE TECHNOLOGIES FOR CANCER RESEARCH (82-109597)
Aug 29, 2022P00001$1.5MCROSS DISCIPLINARY DATA DRIVEN SCIENCE TECHNOLOGIES FOR CANCER RESEARCH (82-109597)
Sep 23, 20210$1.5MCROSS DISCIPLINARY DATA DRIVEN SCIENCE TECHNOLOGIES FOR CANCER RESEARCH (82-109597)

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.